(Q43459677)

English

CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma

scientific article published on 9 April 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

CIP2A expression is associated with altered expression of epithelial-mesenchymal transition markers and predictive of poor prognosis in pancreatic ductal adenocarcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

based on heuristic

inferred from title

author name string

Lei Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Feng Gu

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ning Ma

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Lei Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Jian-Min Bian

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Hong-Yong Cao

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

publication date

9 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

2309-2313

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Treatment for pancreatic cancer: current therapy and continued progress

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

Tumor-derived pancreatic stellate cells promote pancreatic cancer cell invasion through release of thrombospondin-2.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

CIP2A inhibits PP2A in human malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

The role of CIP2A in oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

CIP2A is associated with human breast cancer aggressivity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

CIP2A expression is increased in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

CIP2A protein expression in high-grade, high-stage bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

Non-Hodgkin lymphoma: an update

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0775-2

21 January 2018

CIP2A expression is elevated in cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23568706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Location, location, location: precursors and prognoses for pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23568706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23568706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-0775-2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43459677&oldid=2206052675"